Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

2.0K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
2.0K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.7K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

1.5K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.5K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

4.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.8K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

1.1K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Forecasting seasonal allergic rhinitis through integrated analysis of social media and online drug sales data.

The World Allergy Organization journal·2026
Same author

Allergy to Cats: Current Perspectives and Therapeutic Options.

Clinical and translational allergy·2026
Same author

Diversity and Dosage Determine the Efficacy of the Probiotic SYN-53 in Allergic Rhinoconjunctivitis: A Randomized, Double-Blind, Placebo-Controlled Trial.

Allergy·2025
Same author

Eosinophils in asthma phenotypes: perpetrators or guilty by association?

The Lancet. Respiratory medicine·2025
Same author

Effect of the Multi-Strain Probiotic SYN-53 in the Management of Allergic Rhinoconjunctivitis.

Allergy·2025
Same author

Biologics in allergology and clinical immunology: Update on therapies for atopic diseases, urticaria, and angioedema and on safety aspects focusing on hypersensitivity reactions.

Allergologie select·2024

Related Experiment Video

Updated: Mar 21, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.6K

[Bronchial asthma - many types, different therapies].

Karl-Christian Bergmann

    Deutsche Medizinische Wochenschrift (1946)
    |May 14, 2016
    PubMed
    Summary

    Bronchial asthma affects 9% of Germans, impacting quality of life. Effective treatment, including advanced therapies and specialist care, aims for symptom-controlled asthma and normal daily activities.

    Area of Science:

    • Pulmonology
    • Clinical Medicine

    Background:

    • Bronchial asthma affects approximately 9% of the German population.
    • The condition significantly reduces patients' quality of life and daily performance.
    • Disease triggers and progression vary widely among individuals.

    Purpose of the Study:

    • To outline the therapeutic approach for bronchial asthma.
    • To emphasize the goal of achieving controlled asthma with minimal symptoms and medication reliance.
    • To highlight the role of escalating treatment strategies, including biologicals, in managing the condition.

    Main Methods:

    • Initial asthma management by general practitioners for mild stages (1 and 2).
    • Referral to specialists if initial medication proves insufficient.
    • Implementation of a multi-step escalation of therapy, incorporating modern biological treatments.

    More Related Videos

    A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
    05:56

    A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

    Published on: May 12, 2023

    5.7K
    Methodology for Sputum Induction and Laboratory Processing
    13:28

    Methodology for Sputum Induction and Laboratory Processing

    Published on: December 17, 2017

    29.0K

    Related Experiment Videos

    Last Updated: Mar 21, 2026

    Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
    14:39

    Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

    Published on: November 4, 2010

    32.6K
    A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
    05:56

    A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

    Published on: May 12, 2023

    5.7K
    Methodology for Sputum Induction and Laboratory Processing
    13:28

    Methodology for Sputum Induction and Laboratory Processing

    Published on: December 17, 2017

    29.0K

    Main Results:

    • Mild asthma can be managed by general practitioners.
    • Specialists offer advanced treatment options for difficult-to-control asthma.
    • Escalated therapy, including biologicals, expands possibilities for disease control.

    Conclusions:

    • Controlled asthma management is achievable through a staged therapeutic approach.
    • Specialist intervention and advanced therapies like biologicals are crucial for severe or refractory cases.
    • The ultimate aim is to enable patients to lead active lives with minimal asthma-related limitations.